SCHEMBL7900424

SCHEMBL7900424

Cc1cc(Cl)cc(C(=O)Nc2cccc(Cl)c2)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
GRM4 Q14833 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
KMT2A Q03164 5/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
NPC1 O15118 5/20 0.57
RAB9A P51151 5/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
TP53 P04637 1/20 0.57
NFKB1 P19838 1/20 0.57
MAPK1 P28482 1/20 0.57
NFKB2 Q00653 1/20 0.57
RELA Q04206 1/20 0.57
AHR P35869 2/20 0.56
THRB P10828 1/20 0.56
MEN1 O00255 4/20 0.56
LMNA P02545 3/20 0.54
POLB P06746 2/20 0.54
TSHR P16473 1/20 0.54
HSD17B10 Q99714 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3104769 0.90 SCN2A (0.57) ALDH1A1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL7913043 0.87 SMN1; SMN2 (0.67) KMT2ANPC1RAB9ASMN1; SMN2MEN1
SCHEMBL4906352 0.87 GRM4 (0.64) ALDH1A1GRM4HDAC6KMT2AL3MBTL1
SCHEMBL7913781 0.84 ALDH1A1 (0.52) ALDH1A1GRM4HDAC6KMT2AL3MBTL1
SCHEMBL13148098 0.84 L3MBTL1 (0.54) ALDH1A1GRM4HDAC6KMT2AL3MBTL1
SCHEMBL1795610 0.82 SMN1; SMN2 (0.51) ALDH1A1GRM4HDAC6KMT2AL3MBTL1
SCHEMBL7913044 0.81 SORT1 (0.58) GRM4HDAC6KMT2ANPC1RAB9A
SCHEMBL7910101 0.80 SMARCA2 (0.59) GRM4HDAC6NPC1RAB9ASMN1; SMN2
SCHEMBL7910110 0.79 GRM5 (0.72) KMT2ANPC1RAB9ASMN1; SMN2TP53
SCHEMBL1795347 0.78 CYP1A2 (0.48) ALDH1A1GRM4HDAC6KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010100050-A1 PYRIDINE-2-YL-CARBOXYLIC ACID AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2010-09-10 WO disclosed
US-20100227887-A1 PYRIDINE-2-YL CARBOXYLIC ACID AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2010-09-09 US disclosed
US-20100227887-A1 PYRIDINE-2-YL CARBOXYLIC ACID AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2010-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100227887-A1 PYRIDINE-2-YL CARBOXYLIC ACID AMIDES GRM2, GRM1, GRM3 ALDH1A1 852/4885GRM4 7/4885HDAC6 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.